Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Beam Therapeutics revenue
Beam Therapeutics's revenue is $63.5 million.
What is Beam Therapeutics's revenue?
- Beam Therapeutics's revenue growth from 2019 to 2024 is 352,777.78%.
- Beam Therapeutics has 253 employees, and the revenue per employee ratio is $251,059.
- Beam Therapeutics's peak quarterly revenue was $316.2M in 2023(q4).
- Beam Therapeutics peak revenue was $377.7M in 2023.
- Beam Therapeutics annual revenue for 2023 was 377.7M, 520.01% growth from 2022.
- Beam Therapeutics annual revenue for 2024 was 63.5M, -83.18% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Beam Therapeutics historical revenue
Beam Therapeutics's peak revenue was $377.7M in 2023. The peak quarterly revenue was $316.2M in 2023(q4).
Beam Therapeutics's revenue increased from $18.0k in 2019 to $63.5M currently. That's a 352,777.78% change in annual revenue.
Beam Therapeutics annual revenue
Beam Therapeutics annual revenue over time
| Fiscal year / year | Beam Therapeutics revenue |
|---|---|
| 2019 | $18,000 |
| 2020 | $24,000 |
| 2021 | $51.8M |
| 2022 | $60.9M |
| 2023 | $377.7M |
| 2024 | $63.5M |
Rate Beam Therapeutics' financial transparency
Beam Therapeutics annual growth
Beam Therapeutics saw the greatest revenue growth in 2021, when revenue increased by 215,916.67%.
Beam Therapeutics had the lowest revenue growth in 2022, when revenue changed by 17.51%.
Beam Therapeutics annual growth rate over time
| Year | Beam Therapeutics growth |
|---|---|
| 2020 | 33%↑ |
| 2021 | 215917%↑ |
| 2022 | 18%↑ |
| 2023 | 520%↑ |
| 2024 | -83%↓ |
Beam Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Beam Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | - | - | $6,000 |
| 2020 | $6,000 | $6,000 | $6,000 | $6,000 |
| 2021 | $6,000 | $6,000 | $763,000 | $51.1M |
| 2022 | $8.4M | $16.7M | $15.8M | $20.0M |
| 2023 | $24.2M | $20.1M | $17.2M | $316.2M |
| 2024 | $7.4M | $11.8M | $14.3M | $30.1M |
Beam Therapeutics jobs nearby
Do you work at Beam Therapeutics?
Is Beam Therapeutics transparent about its revenue structure?
Beam Therapeutics financial information
| CEO | John Evans |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 253 |
| Date Founded | 2017 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $63.5M |
| Net Income | -$289,088,000 |
| Tax Rate | -0.0% |
| Total Assets | $1,341,714,000 |
| Ticker | BEAM |
Beam Therapeutics jobs you might like
Beam Therapeutics financing
Beam Therapeutics received early financing of $87.0M on 2018-05-14.
| Series | Round size | Date |
|---|---|---|
| Series A | $87M | 05/2018 |
| Series B | $135M | 03/2019 |
| Post Ipo Equity | $207M | 02/2020 |
| Post Ipo Equity | $260M | 01/2021 |
Beam Therapeutics investors
| Investors | Security type |
|---|---|
| Osage Partners | Series A |
| ARCH Venture Partners | Series A |
| F-Prime Capital | Series A |
| Redmile Group | Series B |
| Altitude Life Science Ventures | Series B |
| Eight Roads Ventures | Series B |
| Cormorant Asset Management | Series B |
| Omega Funds | Series B |
| ARCH Venture Partners | Series B |
| F-Prime Capital | Series B |
| GV | Series B |
| Redmile Group | Post Ipo Equity |
| Cormorant Asset Management | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| Farallon Capital Management | Post Ipo Equity |
| Casdin Capital | Post Ipo Equity |
Beam Therapeutics competitors
Beam Therapeutics's top competitor, Semma Therapeutics, earned an annual revenue of $34.9M.
Beam Therapeutics's smallest competitor is LifeMine with revenue of $1.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Omeros | - | $29.9M | 265 | - |
| Sesen Bio | - | $19.6M | 35 | - |
| Immunome | - | $9.0M | 29 | - |
| Novan | - | $23.7M | 63 | - |
| Argos Therapeutics | - | $1.9M | 76 | - |
| Genomics plc | - | $3.8M | 91 | - |
| PharmaJet | - | $13.5M | 50 | - |
| Semma Therapeutics | - | $34.9M | 75 | - |
| LifeMine | - | $1.4M | 108 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Beam Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Beam Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Beam Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Beam Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Beam Therapeutics. The data presented on this page does not represent the view of Beam Therapeutics and its employees or that of Zippia.
Beam Therapeutics may also be known as or be related to BEAM THERAPEUTICS INC., Beam Therapeutics and Beam Therapeutics Inc.